The findings from this study highlight the dilemma of distinguishing iron deficiency anemia from AI, which remains a frequent clinical challenge despite the availability of tests such as the soluble transferrin receptor (sTfR), a marker of increased erythropoiesis and iron deficiency [28]. This evidence concerns the gene TFRC and anemia.